health benefit

Research in Review

Specialized Surveillance Cost-Effective, Not Linked to Overtreatment in High-Risk Melanoma Population

12/13/2016

JCP Editors

A specialized surveillance program designed to monitor individuals deemed at high risk for melanoma proved cost-effective and may reduce overtreatment rates compared with standard care, according to study results...

A...

12/13/2016

Journal of Clinical Pathways

News

IBM‚Äôs Watson Agrees With Oncologist Treatment Decisions 90% of the Time

12/12/2016

JCP Editors

IBM’s Watson for Oncology, a computer that helps oncologists make treatment decisions for individual patients, made the same recommendations 90% of the time as a team of specialist oncologists, according to a new...

IBM’s...

12/12/2016

Journal of Clinical Pathways

Research in Review

Stepped Care Program Targeting Psychological Distress Deemed Cost-Effective

12/09/2016

JCP Editors

A stepped care program has been deemed more cost-effective than care-as-usual in patients with head and neck cancer or lung cancer who have psychological distress, according to a recent study published in the Journal...

A...

12/09/2016

Journal of Clinical Pathways

Research in Review

Primary Prophylaxis for Breast Cancer Offers Little Benefit

11/07/2016

JCP Editors

The use of white blood cell growth stimulating factor drugs to reduce risk of neutropenia-related complications in women with breast cancer receiving common first-cycle chemotherapies had only a low-to-modest benefit...

The...

11/07/2016

Journal of Clinical Pathways

Drug Combination Reduces Adverse Events and Need for Dose Reductions

06/02/2016

JCP Editors

The addition of plinabulin to non-small cell lung cancer (NSCLC) treatment with docetaxel may reduce the frequency of adverse events and help prevent dose reductions due to toxicity, according to an abstract at the...

The...

06/02/2016

Journal of Clinical Pathways

Research in Review

Nutritional Status an Indicator of Survival in Patients With Esophageal Cancer

05/25/2016

JCP Editors

Nutritional status may be a prominent indicator of survival in elderly patients with esophageal cancer, claims a recently published study. Esophageal cancer is one of the leading causes of cancer-related death...

...

05/25/2016

Journal of Clinical Pathways

Nivolumab More than Doubles One-Year Overall Survival in Head/Neck Cancer

04/27/2016

JCP Editors

Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...

...

04/27/2016

Journal of Clinical Pathways

Genetic Biomarkers Predict Treatment Outcomes for Patients With Breast Cancer

04/25/2016

JCP Editors

Results from a clinical trial presented at the 2016 American Association for Cancer Research Annual Meeting (April 16-20; New Orleans, LA) identified two genetic biomarkers capable of predicting which patients with...

...

04/25/2016

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways

Research in Review

Patients With Prostate Cancer Do Not Benefit From Higher Doses of Radiotherapy

04/06/2016

JCP Editors

While advances in technology have allowed physicians to administer higher doses of radiation to treat prostate cancer, results from a recent study have revealed that escalating dose may not help patients in the long...

While...

04/06/2016

Journal of Clinical Pathways